Evidence map›Paper›PMID 36607999›Full record

ArticlePloS one2023

Prostatic urinary tract visualization with super-resolution deep learning models.

Takaaki Yoshimura, Kentaro Nishioka, Takayuki Hashimoto, Takashi Mori, Shoki Kogame, Kazuya Seki, Hiroyuki Sugimori, Hiroko Yamashina, Yusuke Nomura, Fumi Kato and 3 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 9 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Takaaki YoshimuraDepartment of Health Sciences and Technology, Faculty of Health Sciences, Hokkaido University, Sapporo, Japan.ORCID 0000-0002-6663-4335
Kentaro NishiokaDepartment of Radiation Medical Science and Engineering, Faculty of Medicine, Hokkaido University, Sapporo, Japan.ORCID 0000-0002-8272-7603
Takayuki HashimotoDepartment of Radiation Medical Science and Engineering, Faculty of Medicine, Hokkaido University, Sapporo, Japan.ORCID 0000-0001-5276-3665
Takashi MoriDepartment of Radiation Oncology, Hokkaido University Hospital, Department of Radiation Oncology, Hokkaido University Hospital, Sapporo, Japan.ORCID 0000-0001-5246-215X
Shoki KogameDivision of Radiological Science and Technology, Department of Health Sciences, School of Medicine, Hokkaido University, Sapporo, Japan.
Kazuya SekiDivision of Radiological Science and Technology, Department of Health Sciences, School of Medicine, Hokkaido University, Sapporo, Japan.
Hiroyuki SugimoriDepartment of Biomedical Science and Engineering, Faculty of Health Sciences, Hokkaido University, Sapporo, Japan.
Hiroko YamashinaDepartment of Biomedical Science and Engineering, Faculty of Health Sciences, Hokkaido University, Sapporo, Japan.ORCID 0000-0003-1357-0873
Yusuke NomuraDepartment of Radiation oncology, Stanford University, Stanford, CA, United States of America.
Fumi KatoDepartment of Diagnostic and Interventional Radiology, Hokkaido University Hospital, Sapporo, Japan.
Kohsuke KudoDepartment of Diagnostic Imaging, Faculty of Medicine, Hokkaido University, Sapporo, Japan.ORCID 0000-0001-5351-9242
Shinichi ShimizuDepartment of Medical Physics, Hokkaido University Hospital, Sapporo, Japan.
Hidefumi AoyamaDepartment of Radiation Oncology, Faculty of Medicine, Hokkaido University, Sapporo, Japan.
Hokkaido University · JPSapporo Medical University · JPHokkaido University Hospital · JPHealth Sciences University of Hokkaido · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In urethra-sparing radiation therapy, prostatic urinary tract visualization is important in decreasing the urinary side effect. A methodology has been developed to visualize the prostatic urinary tract using post-urination magnetic resonance imaging (PU-MRI) without a urethral catheter. This study investigated whether the combination of PU-MRI and super-resolution (SR) deep learning models improves the visibility of the prostatic urinary tract. We enrolled 30 patients who had previously undergone real-time-image-gated spot scanning proton therapy by insertion of fiducial markers. PU-MRI was performed using a non-contrast high-resolution two-dimensional T2-weighted turbo spin-echo imaging sequence. Four different SR deep learning models were used: the enhanced deep SR network (EDSR), widely activated SR network (WDSR), SR generative adversarial network (SRGAN), and residual dense network (RDN). The complex wavelet structural similarity index measure (CW-SSIM) was used to quantitatively assess the performance of the proposed SR images compared to PU-MRI. Two radiation oncologists used a 1-to-5 scale to subjectively evaluate the visibility of the prostatic urinary tract. Cohen's weighted kappa (k) was used as a measure of agreement of inter-operator reliability. The mean CW-SSIM in EDSR, WDSR, SRGAN, and RDN was 99.86%, 99.89%, 99.30%, and 99.67%, respectively. The mean prostatic urinary tract visibility scores of the radiation oncologists were 3.70 and 3.53 for PU-MRI (k = 0.93), 3.67 and 2.70 for EDSR (k = 0.89), 3.70 and 2.73 for WDSR (k = 0.88), 3.67 and 2.73 for SRGAN (k = 0.88), and 4.37 and 3.73 for RDN (k = 0.93), respectively. The results suggest that SR images using RDN are similar to the original images, and the SR deep learning models subjectively improve the visibility of the prostatic urinary tract.

Indexed as

Deep LearningHumansImage Processing, Computer-AssistedMagnetic Resonance ImagingMaleProstateReproducibility of ResultsUrethra

Identifiers

PMID36607999
PMCPMC9821403
OpenAlexW4313644314

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.